Tagged with R

MEA The latest COVID-19 vaccine news from the Middle East & Africa (MEA) region, including the fallout from Iran’s ban on any imports of US- or UK-produced vaccines, Israel’s world-leading vaccination speed; and how Dubai Airports is working with GMR-Hyderabad to form a ‘vaccine corridor’.   Iran inks deal for Cuban…

Norway Photodynamic therapy (PDT) firm Photocure is probably Norway’s most significant recent international healthcare success story. CEO Dan Schneider explains how the company was able to action a more effective global commercial strategy and carve out a niche in the relatively uncrowded oncology drug-device combination market.   Despite its technology being…

Global Following the recent news of Remegen’s massive USD 515 million IPO in November 2020, we bring you profiles of the seven biggest biotech companies to IPO in 2020. Notably, six of the seven companies are from China, pointing to the massive growth of the Chinese biotech market.   Remegen RemeGen,…

Norway Norway has long held a strong international position in neuroscience and is home to Professors May-Britt and Edvard Moser, a married couple and the 2014 winners of the Nobel Prize in Physiology or Medicine. The Mosers, along with their former mentor John O’Keefe, won the award for their work on…

Norway Many countries have struggled to adapt to the shift to remote working and digital communication brought about by the COVID-19 pandemic and subsequent lockdowns. However, these tools were already well-utilised in the vast but sparsely populated country of Norway and digital is increasingly being seen as a key component in…

Saudi Arabia Following on from our list of the overall top 10 companies in the Saudi Arabian pharma market, here PharmaBoardroom highlights some of the top domestic companies in the USD 8.2 billion Saudi pharma market, many of which are now well-established and carving out international footprints.   Tabuk Pharmaceuticals Founded in…

Europe On 25 November 2020, the European Commission adopted a Pharmaceutical Strategy for Europe with the stated aim of ensuring that “patients have access to innovative and affordable medicines” and “to support the competitiveness, innovative capacity and sustainability of the EU’s pharmaceutical industry”.   This Pharmaceutical Strategy for Europe is seen…

Switzerland Chief Financial Officer Marina Lugova introduces pharmaceutical company Synbias Pharma’s evolving European footprint, how the company has been able to withstand the COVID-19 pandemic and continue providing its essential products to customers, and its plans for the future, including further investments in the firm’s German production facility and new strategic…

Switzerland As part of the Federal Department of Home Affairs, the Federal Office of Public Health (FOPH) is responsible for public health in Switzerland; developing the country’s health policy and working to create an efficient and affordable healthcare system in the long term. PharmaBoardroom recently sat down with the FOPH’s newly…

China The latest from Chinese pharma, including domestic regulatory approval for Sinopharm’s COVID-19 vaccine, how the country’s online healthcare industry is booming in the wake of the pandemic, and news that companies are slashing prices on new products by an average of 51 percent in order for them to be covered…

USA A Tale of Two Americas The US stands as the biopharma innovation champion of the world, a global leader on nearly all R&D indices related to investment and innovation. It also holds a tremendous amount of clout, representing half the world’s healthcare market, and the US healthcare industry itself is…

Global While great strides in gender diversity has been made within healthcare boardrooms and leadership teams globally, as well as more generally across the workplace and many other arenas in many countries, at times we are served a stark reminder that the fight for greater gender equality and women representation is…